Average Co-Inventor Count = 7.57
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (49 from 290 patents)
2. Elmore Patent Law Group, P.c. (1 from 1 patent)
3. Enanta Pharmacueticals, Inc. (1 from 1 patent)
51 patents:
1. 12479854 - Spiropyrrolidine derived antiviral agents
2. 12459923 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
3. 12384753 - 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
4. 12281140 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
5. 12018017 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
6. 12006291 - Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid
7. 11976084 - Spiropyrrolidine derived antiviral agents
8. 11958879 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
9. 11945824 - Heterocyclic compounds as anti-viral agents
10. 11919910 - Spiropyrrolidine derived antiviral agents
11. 11912714 - Spiropyrrolidine derived antiviral agents
12. 11834436 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
13. 11718641 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
14. 11560368 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
15. 11555032 - Isoxazole derivatives as FXR agonists and methods of use thereof